Toggle navigation
Content library
Alzheimer's & Neurodegenerative Diseases
Clinical Assessment
Fluid Biomarkers
Imaging
Management of ARIA
Biostatistics
Case Studies
Treatment
Congresses
BiogenAD symposium
AD Symposium Comprehensive Cognitive Assessment 2020 CA
AD Symposium Evaluating Pathological Biomarkers 2020 CA
AD Symposium Healthcare System Readiness 2020 CA
AD Symposium Case Study2020 CA
Preparing the health system: where do we go from here?
Leveraging biomarkers for an earlier diagnosis of AD
The challenges we face in advancing the AD clinical and research landscape
Pursuing a memory complain: how do we better detect and refer patients earlier?
Learning Programs
Other Resources
Cookies
Subscribe
Thank you
Expert Perspectives
To what extent do you believe the guidelines presented (WHO and Lancet Commission) will have an impact on clinical practice in Alzheimer’s disease?
What is the most important scientific update in terms of advancing the AD field from AAIC, and why?
What is your key takeaway for the Alzheimer’s disease community from AAIC?
What updates from AAIC do you consider to have the greatest impact on your clinical practice, and why?
What updates from CTAD do you consider to have the greatest impact on your clinical practice, and why? Perspectives from Dr. Sophie Auriacombe
What updates from CTAD do you consider to have the greatest impact on your clinical practice, and why? Perspectives from Dr. John Morgan
What is your key takeaway for the Alzheimer's disease community from CTAD? Perspectives from Jill Rasmussen
What is your key takeaway for the Alzheimer's disease community from CTAD? Perspectives from Dr. Collin Liu
To what extent do you believe the guidelines presented (WHO and Lancet Commission) will have an impact on clinical practice in Alzheimer’s disease?
What is the most important scientific update in terms of advancing the AD field from AAIC, and why?
What is your key takeaway for the Alzheimer’s disease community from AAIC?
What updates from AAIC do you consider to have the greatest impact on your clinical practice, and why?
What updates from CTAD do you consider to have the greatest impact on your clinical practice, and why? Perspectives from Dr. Sophie Auriacombe
What updates from CTAD do you consider to have the greatest impact on your clinical practice, and why? Perspectives from Dr. John Morgan
What is your key takeaway for the Alzheimer's disease community from CTAD? Perspectives from Jill Rasmussen
What is your key takeaway for the Alzheimer's disease community from CTAD? Perspectives from Dr. Collin Liu
To what extent do you believe the guidelines presented (WHO and Lancet Commission) will have an impact on clinical practice in Alzheimer’s disease?
